# Newmarket Corp: overview

NEU · NYSE · CIK 1282637 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/neu.md) · [Financials](/companies/neu/financials.md) · [Filings](/companies/neu/filings.md) · [Insiders](/companies/neu/insiders.md)

Latest reported revenue: [$716.5m](/filings/0001282637-26-000020.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001282637-26-000020).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [655 d](/filings/0001282637-26-000005.md) | [701](/filings/0001282637-26-000009.md) | [699](/filings/0001282637-26-000016.md) | [690](/filings/0001282637-26-000020.md) | [635 d](/filings/0001282637-26-000005.md) | [670](/filings/0001282637-26-000009.md) | [747](/filings/0001282637-26-000016.md) | [717](/filings/0001282637-26-000020.md) |
| Gross margin | % | [31.7% d](/filings/0001282637-26-000005.md) | [33.7%](/filings/0001282637-26-000009.md) | [31.6%](/filings/0001282637-26-000016.md) | [30.4%](/filings/0001282637-26-000020.md) | [30.0% d](/filings/0001282637-26-000005.md) | [33.0%](/filings/0001282637-26-000009.md) | [32.4%](/filings/0001282637-26-000016.md) | [31.0%](/filings/0001282637-26-000020.md) |
| Operating margin | % | [20.3% d](/filings/0001282637-26-000005.md) | [22.8%](/filings/0001282637-26-000009.md) | [20.5%](/filings/0001282637-26-000016.md) | [18.9%](/filings/0001282637-26-000020.md) | [17.3% d](/filings/0001282637-26-000005.md) | [21.4%](/filings/0001282637-26-000009.md) | [21.9%](/filings/0001282637-26-000016.md) | [20.0%](/filings/0001282637-26-000020.md) |
| Net margin | % | [16.9% d](/filings/0001282637-26-000005.md) | [18.0%](/filings/0001282637-26-000009.md) | [15.9%](/filings/0001282637-26-000016.md) | [14.5%](/filings/0001282637-26-000020.md) | [12.8% d](/filings/0001282637-26-000005.md) | [17.6%](/filings/0001282637-26-000009.md) | [17.9%](/filings/0001282637-26-000016.md) | [17.3%](/filings/0001282637-26-000020.md) |
| Diluted EPS | $ per share | not reported | [13.26](/filings/0001282637-26-000009.md) | [11.84](/filings/0001282637-26-000016.md) | [10.67](/filings/0001282637-26-000020.md) | not reported | [12.62](/filings/0001282637-26-000009.md) | [14.54](/filings/0001282637-26-000016.md) | [13.50](/filings/0001282637-26-000020.md) |
| Free cash flow | $m | [171 d](/filings/0001282637-26-000005.md) | [107](/filings/0001282637-26-000009.md) | [140 d](/filings/0001282637-26-000016.md) | [112 d](/filings/0001282637-26-000020.md) | [117 d](/filings/0001282637-26-000005.md) | [99.7](/filings/0001282637-26-000009.md) | [135 d](/filings/0001282637-26-000016.md) | [31.8 d](/filings/0001282637-26-000020.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,356](/filings/0001282637-24-000005.md) | [2,765](/filings/0001282637-25-000004.md) | [2,698](/filings/0001282637-26-000005.md) | [2,787](/filings/0001282637-26-000005.md) | [2,725](/filings/0001282637-26-000005.md) |
| Gross margin | % | [23.2%](/filings/0001282637-24-000005.md) | [23.2%](/filings/0001282637-25-000004.md) | [28.6%](/filings/0001282637-26-000005.md) | [31.8%](/filings/0001282637-26-000005.md) | [31.5%](/filings/0001282637-26-000005.md) |
| Operating margin | % | [10.9%](/filings/0001282637-24-000005.md) | [12.8%](/filings/0001282637-25-000004.md) | [17.9%](/filings/0001282637-26-000005.md) | [21.2%](/filings/0001282637-26-000005.md) | [20.0%](/filings/0001282637-26-000005.md) |
| Net margin | % | [8.1%](/filings/0001282637-24-000005.md) | [10.1%](/filings/0001282637-25-000004.md) | [14.4%](/filings/0001282637-26-000005.md) | [16.6%](/filings/0001282637-26-000005.md) | [15.4%](/filings/0001282637-26-000005.md) |
| Diluted EPS | $ per share | [17.71](/filings/0001282637-24-000005.md) | [27.77](/filings/0001282637-25-000004.md) | [40.44](/filings/0001282637-26-000005.md) | [48.22](/filings/0001282637-26-000005.md) | [44.44](/filings/0001282637-26-000005.md) |
| Free cash flow | $m | [86.4](/filings/0001282637-24-000005.md) | [52.5](/filings/0001282637-25-000004.md) | [529](/filings/0001282637-26-000005.md) | [462](/filings/0001282637-26-000005.md) | [491](/filings/0001282637-26-000005.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/neu/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $556.3m | 703,123 |  | Reduced −13,560 |
| [LONDON CO OF VIRGINIA](/funds/1259887.md) | 2026-06-30 | $386.5m | 488,482 |  | Added +27,455 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $329.2m | 416,063 |  | Reduced −34,417 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $276.0m | 348,834 |  | Reduced −5,457 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $256.0m | 323,902 |  | Added +72,780 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $213.6m | 270,011 |  | Added +151,670 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $185.9m | 234,065 |  | Added +422 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $165.7m | 209,436 |  | Added +40,792 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $162.7m | 205,661 |  | Added +11,154 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $151.1m | 190,942 |  | Added +6,212 |

## Recent filings

[All 820 filings](/companies/neu/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 17:05 ET | [8-K](/filings/0001193125-26-438002.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-438002 |
| 2026-10-29 | 08:48 ET | [10-Q](/filings/0001282637-26-000020.md) | Quarterly report, period 2026-09-30 | 0001282637-26-000020 |
| 2026-10-28 | 17:12 ET | [8-K](/filings/0001282637-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001282637-26-000019 |
| 2026-08-13 | 17:05 ET | [8-K](/filings/0001193125-26-349568.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-349568 |
| 2026-07-30 | 08:42 ET | [10-Q](/filings/0001282637-26-000016.md) | Quarterly report, period 2026-06-30 | 0001282637-26-000016 |
| 2026-07-29 | 17:17 ET | [8-K](/filings/0001282637-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001282637-26-000015 |
| 2026-04-23 | 17:05 ET | [8-K](/filings/0001193125-26-173975.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-173975 |
| 2026-04-23 | 08:53 ET | [10-Q](/filings/0001282637-26-000009.md) | Quarterly report, period 2026-03-31 | 0001282637-26-000009 |
| 2026-04-22 | 17:13 ET | [8-K](/filings/0001282637-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001282637-26-000008 |
| 2026-03-12 | 06:06 ET | [DEF 14A](/filings/0001193125-26-102973.md) | Proxy statement, period 2026-04-23 | 0001193125-26-102973 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001282637-26-000005.md), filed Feb 12, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/a537670c-9e81-4828-964e-774d5a298b33)

## About the filer

- CIK: 1282637
- Tickers: NEU
- Exchange: NYSE
- SIC code: 2860 Industrial Organic Chemicals
- State of incorporation: VA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 19:40 ET. No prices; not investment advice.